 The Guardian | Drug company attacks Nice for rejecting new lupus treatment The Guardian The standard treatment usually consists of non-steroidal anti-inflammatory drugs (NSAIDs), corticosteroids, and/or immunosuppressants such as rituximab in some cases. Around 25000 people are affected in the UK - mostly women aged between 15 and 44. NICE no to GSK's lupus drug Benlysta |
